Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic Biomarker
Recruiting
N/A
Interventional Study
Pulp Disease, Dental
Pulpitis
Reversible Pulpitis
Irreversible Pulpitis (Toothache)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 16 – 50
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Abeer Ghalib Abdul-khaliq · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective controlled clinical trial investigates whether metabolic biomarkers measured in pulpal blood at the time of carious pulp exposure can predict the 12-month outcomes of vital pulp treatment in symptomatic permanent teeth. Eligible patients aged 16-50 years presenting with deep carious pulp exposure will undergo vital pulp therapy (partial pulpotomy or full pulpotomy). Pulpal blood s…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age range of 16-50 years.
2. Pulp exposure during treatment of deep caries.
3. Absence of periodontitis or systemic disease.
4. Only one or two proximal surfaces lost with remaining walls \> 2 mm; and
5. Good compliance and signed informed consent forms.
Exclusion Criteria:
…
Contacts